Michael Bourque Named Chief Financial Officer at Inogen

Inogen Inc. has appointed Michael Bourque as chief financial officer (CFO), succeeding Interim CFO Mike Sergesketter, who will remain in an advisory role during the transition.

“I am incredibly excited to announce Michael as the new chief financial officer of Inogen. His experience building best-in-class finance teams at Chase, Keystone, and Analogic display what makes him qualified to help Inogen continue to deliver respiratory solutions to patients around the world.” Inogen President/CEO Kevin Smith said. “I would also like to thank Mike Sergesketter for once again stepping into the role of CFO during our search. His experience and stewardship helped ensure a smooth transition during the beginning of my tenure and the previous six months.”

Bourque has served as CFO and treasurer of Chase Corporation (now owned by KKR & Co. Inc.) since 2021. He also was CFO of Keystone Dental; senior vice president, CFO and treasurer of Analogic Corporation from 2014 to 2018; and vice president of Finance for Axcelis Technologies from 2011 to 2014.

Bourque earned a bachelor’s degree in accounting from Bentley University. 
 
“I am excited to be joining Inogen at such a pivotal point in the company’s story,” Bourque stated. “It is an incredible opportunity to deliver value to our patients and shareholders.”
 
Inogen Inc. is a global medical technology company offering respiratory products for use in the homecare setting. Inogen supports patient respiratory care by developing, manufacturing, and marketing portable oxygen concentrators used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. Inogen partners with patients, prescribers, home medical equipment providers, and distributors to make its oxygen therapy products widely available, allowing patients the chance to remain ambulatory while managing the impact of their disease.